08.02.2022 • News

Clariant to Sell Scientific Design Stake to SABIC

Clariant has signed definitive agreements to divest its 50% stake in the joint venture that owns Scientific Design Company to its long-term joint venture partner, SABIC. The Saudi group will execute a call option raised in 2015 to acquire the stake in the business bought by Germany’s Süd-Chemie in 2003 prior to its acquisition by Clariant.

Follwing due diligence, the partners agreed to value the US-headquartered JV at $260 million, with Clariant’s 50% share thus worth $130 million. Coupled with a profit-sharing agreement that began on Jan. 1, 2021 and will end with the transaction’s closing, Clariant said this represents an attractive valuation for its stake at around 12 times Scientific Design’s 2021 expected EBITDA, assuming a mid-2022 closing.

For 2020, Scientific Design, based in Little Ferry, New Jersey, reported sales of 121 million Swiss francs. The company is engaged in the development, licensing and catalyst supply of proprietary processes for the production of ethylene oxide (EO), ethylene glycol (EO/EG), bio-ethylene, bio-EO, bio-EG, EO derivatives, polyols and maleic anhydride. It also produces proprietary catalysts and equipment for use in its own and other industrial processes.

Author: Dede Williams, Freelance Journalist

(c) Clariant
(c) Clariant

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read